Individuals infected with HIV will typically be using 2 predominant sets of medications: those for the management of HIV and those for the treatment and/or prophylaxis of opportunistic infections, namely Pneumocystis pneumonia and Mycobacterium avium complex. Highly active antiretroviral therapy (HAAR T)...
Compared with untreated patients, treatment of LF with plasma appeared to have a protective benefit, provided treatment was administered before ten days of symptom onset [109]. When given within ten days, only 1/11 patients had lethal disease, while 8/11 did when treatment started after day te...
Read articles that appeared in the print edition of Infection Disease News here. Healio is your trusted source for infection disease news.
Complete protection was seen in animals treated on day 7, suggesting that there may be differences in the optimal time-to-treatment scenario depending on the infecting virus and the antibodies used for treatment. This underscores the importance of preclinical studies on how well-matched the antibodie...
Pharmacologic treatment is the foundation of TB management. Drugs are given over weeks or months and often involve complex regimens. Active disease and latent infection are treated differently, and the specific path chosen varies depending on patient factors, including HIV status, ext...
Decreased intestinal abundance of Akkermansia muciniphila is associated with metabolic disorders among people living with HIV Zhe Qian, Suling Chen, Xiaoyang Liao, Jingfang Xie, Yuyuan Xu, Huiqun Zhong, Lang Ou, Xiang Zuo, Xuwen Xu, Jie Peng, Jian Wu & Shaohang Cai Article: 2474730 Published...
Inter-individual variability in drug response, be it efficacy or safety, is common and likely to become an increasing problem globally given the growing elderly population requiring treatment. Reasons for this inter-individual variability include genomic
A retrospective analysis of weight changes in HIV-positive patients switching from a tenofovir disoproxil fumarate (TDF)- to a tenofovir alafenamide fumarate (TAF)-containing treatment regimen in one German university hospital in 2015-2017. Infection. 2019;47(1):95–102. https://doi.org/10.1007/...
CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjogren's syn- drome. Clin Exp Rheumatol. 1995;13:609–616. 107. Harel A, Horng S, Gustafson T, Ramineni A, Farber RS, Fabian M. Successful treatment of progressive multifocal leukoencephalopa- thy...
AbstractforA polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials | Full Text | References | PDF (2.1 MB) | EPUB | Supplemental 859 Views 0 Cr...